Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease
- PMID: 25855668
- PMCID: PMC4392846
- DOI: 10.1161/CIRCIMAGING.114.002546
Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease
Abstract
Background: Chronic obstructive pulmonary disease causes significant morbidity and concomitant pulmonary vascular disease and cardiac dysfunction are associated with poor prognosis. Computed tomography-detected relative pulmonary artery (PA) enlargement defined as a PA to ascending aorta diameter ratio >1 (PA:A>1) is a marker for pulmonary hypertension and predicts chronic obstructive pulmonary disease exacerbations. However, little is known about the relationship between the PA:A ratio, pulmonary blood volume, and cardiac function.
Methods and results: A single-center prospective cohort study of patients with chronic obstructive pulmonary disease was conducted. Clinical characteristics and computed tomography metrics, including the PA:A and pulmonary blood vessel volume, were measured. Ventricular functions, volumes, and dimensions were measured by cine cardiac MRI with 3-dimensional analysis. Linear regression examined the relationships between clinical characteristics, computed tomography and cardiac MRI metrics, and 6-minute walk distance. Twenty-four patients were evaluated and those with PA:A>1 had higher right ventricular (RV) end-diastolic and end-systolic volume indices accompanied by lower RV ejection fraction (52±7% versus 60±9%; P=0.04). The PA:A correlated inversely with total intraparenchymal pulmonary blood vessel volume and the volume of distal vessels with a cross-sectional area of <5 mm(2). Lower forced expiratory volume, PA:A>1, and hyperinflation correlated with reduced RV ejection fraction. Both PA diameter and reduced RV ejection fraction were independently associated with reduced 6-minute walk distance.
Conclusions: The loss of blood volume in distal pulmonary vessels is associated with PA enlargement on computed tomography. Cardiac MRI detects early RV dysfunction and remodeling in nonsevere chronic obstructive pulmonary disease patients with a PA:A>1. Both RV dysfunction and PA enlargement are independently associated with reduced walk distance.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608764.
Keywords: cardiac magnetic resonance imaging; hypertension, pulmonary; pulmonary disease; pulmonary heart disease; smoking.
© 2015 American Heart Association, Inc.
Figures
References
-
- Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT. Pulmonary arterial enlargement and acute exacerbations of copd. N Engl J Med. 2012;367:913–921. - PMC - PubMed
-
- Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, Kikinis R, Han MK, Come CE, Diaz AA, Cho MH, Hersh CP, Schroeder JD, Reilly JJ, Lynch DA, Crapo JD, Wells JM, Dransfield MT, Hokanson JE, Washko GR. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188:231–239. - PMC - PubMed
-
- Petty TL. Scope of the copd problem in north america: Early studies of prevalence and nhanes iii data: Basis for early identification and intervention. Chest. 2000;117:326S–331S. - PubMed
-
- Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease. Lung. 2011;189:207–212. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- R01 HL089897/HL/NHLBI NIH HHS/United States
- R01-HL104018/HL/NHLBI NIH HHS/United States
- R01HL116473/HL/NHLBI NIH HHS/United States
- R01HL116473-02/HL/NHLBI NIH HHS/United States
- U01 HL089897/HL/NHLBI NIH HHS/United States
- R01 HL116931/HL/NHLBI NIH HHS/United States
- R01 HL116473/HL/NHLBI NIH HHS/United States
- U01 HL089856/HL/NHLBI NIH HHS/United States
- K08 HL123940/HL/NHLBI NIH HHS/United States
- R01 HL104018/HL/NHLBI NIH HHS/United States
- U01HL089897/HL/NHLBI NIH HHS/United States
- 1R01HL116931-02/HL/NHLBI NIH HHS/United States
- K08 HL1123940/HL/NHLBI NIH HHS/United States
- U01HL089856/HL/NHLBI NIH HHS/United States
- L30 HL120208/HL/NHLBI NIH HHS/United States
- K25 HL104085/HL/NHLBI NIH HHS/United States
- K25 HL104085-04/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
